| S.No |
Product Description |
CAS No |
API |
Therapeutic Area |
| 1 | (R)-3-Aminopiperidine dihydrochloride | 334618-23-4 | Alogliptin | Diabetes |
| 2 | 2-(Bromomethyl) benzonitrile | 22115-41-9 | Alogliptin | Diabetes |
| 3 | 6-Chloro uracil | 4270-27-3 | Alogliptin | Diabetes |
| 4 | 6-Chloro-3-methyluracil | 4318-56-3 | Alogliptin | Diabetes |
| 5 | 1-(4-Iodophenyl)piperidin-2-one | 385425-15-0 | Apixaban | Anticoagulant |
| 6 | 1-(4-Nitrophenyl)piperidin-2-one | 38560-30-4 | Apixaban | Anticoagulant |
| 7 | 2-Methyl-4,6-dichloropyrimidine | 1780-26-3 | Dasatinib | Anti Cancer |
| 8 | 2-Amino-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide | 302964-24-5 | Dasatinib | Anti Cancer |
| 9 | n-HEXYLCHLOROFORMATE | 6092-54-2 | Debigatran | Anticoagulant |
| 10 | 4-(Hydroxymethyl)-5-methyl-1,3-dioxol-2-one | 91526-18-0 | Fabuxostat | Arthritis |
| 11 | diethyl 2-acetamido-2-(4-octylphenethyl)malonate | 162358-08-9 | Fingolimod | Multiple Sclerosis |
| 12 | N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide | 162358-09-0 | Fingolimod | Multiple Sclerosis |
| 13 | N-(3-Chloropropyl)morpholine | 7357-67-7 | Gefitinib | Anti Cancer |
| 14 | 3-O-Benzyl 15,16-Dehydro Estrone | 138743-03-0 | New Product Entity | Estratrienes |
| 15 | 6-CHLORO-8-METHYL-1H-BENZO[D][1,3]OXAZINE-2,4-DIONE | 852519-81-4 | New Product Entity | Estratrienes |
| 16 | Estra 1,3,5,(10)trein-17,1 Phenylmrthoxy propen | 852519-50-7 | New Product Entity | Estratrienes |
| 17 | 2-(2-(2,2,2-Trifluoroethoxy)phenoxy)-ethyl methanesulfonate | 160969-03-9 | Silodosin | Benign prostatic hyperplasia |
| 18 | Ethanol, 2-[2-(2,2,2-trifluoroethoxy)phenoxy] | 160969-02-8 | Silodosin | Benign prostatic hyperplasia |
| 19 | Clomiphene | 911-45-5 | Clomiphene | Activation of Estrogen Receptors |
| 20 | 2-Cyanophenothiazine | 38642-74-9 | Cyamemazine | Antipsychotic |
| 21 | 6 α,9α- difuroprednisolone 17 α,21- Methylorthobutyrate | 23674-86-4 | Difluprednate | Ocular Inflammation and Pain |
| 22 | 6 α,9α- difuroprednisolone 17-butyrate | | Difluprednate | Ocular Inflammation and Pain |
| 23 | Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | 160844-75-7 | Febuxostat | Gout and Hyperuricemia |
| 24 | 2-Methoxy -5-Sulfamoyl methyl benzoate (powder) | 33045-52-2 | Levosulpiride | Psychoses |
| 25 | (S)-N-ethyl-2-amino methyl pyrrolidine (liquid) | 22795-99-9 | Levosulpiride | Psychoses |
| 26 | [(3aR,4S,5R,6aS)-hexahydro-4-(triisopropylsilyloxymethyl)-5- (phenylmethoxy) -2H-cyclopenta[b]furan-2-one] | 32233-40-2 | Lubiprostone | Chronic Idiopathic |
| 27 | 4-(4-Aminophenyl)-3-morpholinone | 438056-69-0 | Rivaroxaban | Anticoagulant |
| 28 | (S)-N-(2,3-Epoxypropan-1-yl)phthalimide | 161596-47-0 | Rivaroxaban | Anticoagulant |
| 29 | 5-[(2R)-2-Aminopropyl]-2,3-dihydro-1-[3-(phenylmethoxy)propyl]-1H-indole-7-carbonitrile | 459868-73-6 | Silodosin | Benign Prostatic Hyperplasia |
| 30 | 2-[[2-(2,2,2-trifluoroethoxy)phenoxy]methyl]-1,3-Dioxolane | 1269801-74-2 | Silodosin | Benign Prostatic Hyperplasia |
| 31 | 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 | Ticagrelor | Heart |
| 32 | Trans-3-methyl-3-cyclohexene-1-carboxylic acid | 10479-42-2 | Trimedlure | Attractant in medfly traps |
| 33 | 4-BROMOMETHYL-2-CYANOBIPHENYL | 114772-54-2 | Valsartan / Telmisartan / Irbesartan | Angiotensin Receptor Blocker |
| 34 | (S)-3-(Aminomethyl)-5-methylhexanoic acid | 148553-50-8 | Pregabalin | Anticonvulsant and Antiepileptic |
| 35 | Estradiene dione-3-keta | 5571-36-8 | Lubiprostone | Irritable bowel syndrome |
| 36 | 1-{[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicycle-[4,2,0]oct- 2-ene-3-yl]-methyl}-pyridinium iodide (7PYCA) | 3422-88-0 | Ceftazidime | Antibiotic |
| 37 | S-2-BENZOTHIAZOLYL (Z)-2-(5-AMINO-1,2,4-THIADIAZOL-3-YL)-2-METHOXYIMINO THIOACETATE (CAEM) | 104797-47-9 | Cefdinir | Antibiotic |
Home
Partnership & Alliances
Custom Synthsis
Manufacturing
Products
News
Contact